A Study on the Treatment of Rheumatoid Arthritis Using a Novel GelMA-HAMA Dual-Network Hydrogel Microneedle Loaded with MTX-NCs in Combination with Adalimumab
International Journal of Molecular Sciences · 23.02.2026 · 27 (4) · 2075
DOI: 10.3390/ijms27042075 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.02.2026. Verfasst von Jianing Tian und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Jiamusi University, Jiamusi 154007, China. Hauptthemen laut MEDLINE: Methotrexate, Arthritis, Rheumatoid, Adalimumab, Hydrogels. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic Research Support Program for Excellent Young Teachers in Heilongjiang Province, Heilongjiang Province Natural Science Foundation.
Abstract (Originalsprache)
This study developed a transdermal drug delivery system for Rheumatoid Arthritis (RA) using a dual-network hydrogel microneedle patch loaded with methotrexate nanocrystals (DHMN@MTX-NCs), and explored its synergistic therapy with Adalimumab (ADA) for a painless, long-acting, and targeted RA treatment. This study synthesized Methacrylated Hyaluronic Acid and Methacrylated Gelatin. MTX-NCs were prepared by solvent-antisolvent precipitation and incorporated into a dual-network hydrogel microneedle patch via centrifugal molding. Evaluations included pharmaceutical properties, mechanical strength, drug release, in vitro anti-inflammatory effects on RAW 264.7 cells, and therapeutic efficacy in a rat RA model. The experimental results show that the prepared MTX-NCs present a spherical shape, an average size of 325.72 nm, a PDI of 0.154, and a drug-loading capacity of 61.3%. The microneedle patch exhibited high puncture efficiency and suitable swelling. In vitro, DHMN@MTX-NCs combined with ADA most strongly inhibited macrophage migration, upregulated IL-10, and downregulated TNF-α, IL-1β, NO, iNOS, and COX-2. In vivo, both monotherapy and combination therapy reduced joint swelling, bone erosion, and histopathological damage. Ultimately, the study demonstrated the synergistic anti-inflammatory efficacy of DHMN@MTX-NCs combined with ADA, providing a novel, non-invasive, and targeted therapeutic strategy for RA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Jiamusi University, Jiamusi 154007, China.
Förderung
- Basic Research Support Program for Excellent Young Teachers in Heilongjiang Province
- Heilongjiang Province Natural Science Foundation
Zitieren
APA
Tian, J., Shi, Y., Liu, C., Liu, M., Li, L., Zhu, Y., Wang, H., Su, J., & Ping, Y. (2026). A Study on the Treatment of Rheumatoid Arthritis Using a Novel GelMA-HAMA Dual-Network Hydrogel Microneedle Loaded with MTX-NCs in Combination with Adalimumab. International Journal of Molecular Sciences, 27(4), 2075. https://doi.org/10.3390/ijms27042075
Vancouver
Tian J, Shi Y, Liu C, Liu M, Li L, Zhu Y, et al. A Study on the Treatment of Rheumatoid Arthritis Using a Novel GelMA-HAMA Dual-Network Hydrogel Microneedle Loaded with MTX-NCs in Combination with Adalimumab. International Journal of Molecular Sciences. 2026;27(4):2075. doi:10.3390/ijms27042075
BibTeX
@article{Tian2026,
author = {Tian, Jianing and Shi, Yuhang and Liu, Chunyu and Liu, Mu and Li, Lin and Zhu, Yusi and Wang, Huilin and Su, Jin and Ping, Yang},
title = {A Study on the Treatment of Rheumatoid Arthritis Using a Novel GelMA-HAMA Dual-Network Hydrogel Microneedle Loaded with MTX-NCs in Combination with Adalimumab},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {4},
pages = {2075},
doi = {10.3390/ijms27042075}
}
EUVIMED